Theranostics
About Theranostics
Theranostics publishes innovative research articles reflecting the fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology and translational medicine, personalized medicine and a broad spectrum of biomedical research that can be applied to future theranostic applications.
- Website: https://www.thno.org/
- Current Issue: https://www.thno.org/currentissue
News
25 Mar 2026
National Taiwan University
National Taiwan University researchers have engineered a dual-targeting nanocarrier that safely sneaks potent chemotherapy past the blood-brain barrier. By homing in on a specific protein (FAP) expressed by both the glioblastoma cells and their protective “helper” cells, this approach directly shrinks the deadly tumor while reprogramming the immune system to join the fight.
26 Dec 2025
Daegu Gyeongbuk Institute of Science and Technology (DGIST)
- DGIST-iProtein Therapeutics Joint Research Team innovatively enhances the binding strength and stability of IL-1Ra protein using supercomputing and structure-based design technologies.
- The new variant 'E127Q' shows anti-inflammatory and neuroprotective effects that surpass existing treatments in cell and animal models.
26 Dec 2025
Daegu Gyeongbuk Institute of Science and Technology (DGIST)
- Research team headed by DGIST Professors Jaewon Ko and Jiwon Um, confirmed the functional recovery of neurons after directly dissolving toxic protein aggregates in the brain
- Degenerative diseases, including Huntington’s disease emerging as new targets of ‘cleaner protein within the brain,’ ClpB
05 Aug 2025
National Taiwan University
A research team at National Taiwan University has developed a new stem cell-based vaccine that could help prevent and treat colorectal cancer.
04 Jul 2023
Daegu Gyeongbuk Institute of Science and Technology (DGIST)
- Professor Minseok Kim’s team at the DGIST confirmed the excellent anticancer effects of the NK cell therapy product that can self-activate in preclinical trials with CT Cells
- This work is expected to be applied in various fields as a next-generation anticancer therapy using NK cells
21 Jun 2022
Daegu Gyeongbuk Institute of Science and Technology (DGIST)
A machine rapidly and robustly separates cancer cells from blood samples, overcoming challenges with currently available techniques.